본문 바로가기
KERD
논문KCI 등재

Genomic characterization of clonal evolution during oropharyngeal carcinogenesis driven by human papillomavirus 16

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류화학

초록

Secondary prevention via earlier detection would afford the greatest chance for a cure in premalignant lesions. We investigated the exomic profiles of non-malignant and malignant changes in head and neck squamous cell carcinoma (HNSCC) and the genomic blueprint of human papillomavirus (HPV)-driven carcinogenesis in oropharyngeal squamous cell carcinoma (OPSCC). Whole-exome (WES) and whole-genome (WGS) sequencing were performed on peripheral blood and adjacent non-tumor and tumor specimens obtained from eight Korean HNSCC patients from 2013 to 2015. Next-generation sequencing yielded an average coverage of 94.3× for WES and 35.3× for WGS. In comparative genomic analysis of non-tumor and tumor tissue pairs, we were unable to identify common cancer-associated early mutations and copy number alterations (CNA) except in one pair. Interestingly, in this case, we observed that non-tumor tonsillar crypts adjacent to HPV-positive OPSCC appeared normal under a microscope; however, this tissue also showed weak p16 expression. WGS revealed the infection and integration of high-risk type HPV16 in this tissue as well as in the matched tumor. Furthermore, WES identified shared and tumor-specific genomic alterations for this pair. Clonal analysis enabled us to infer the process by which this transitional crypt epithelium (TrCE) evolved into a tumor; this evolution was accompanied by the subsequent accumulation of genomic alterations, including an ERBB3 mutation and large-scale CNAs, such as 3q27-qter amplification and 9p deletion. We suggest that HPV16-driven OPSCC carcinogenesis is a stepwise evolutionary process that is consistent with a multistep carcinogenesis model. Our results highlight the carcinogenic changes driven by HPV16 infection and provide a basis for the secondary prevention of OPSCC.

Abstract

Secondary prevention via earlier detection would afford the greatest chance for a cure in premalignant lesions. We investigated the exomic profiles of non-malignant and malignant changes in head and neck squamous cell carcinoma (HNSCC) and the genomic blueprint of human papillomavirus (HPV)-driven carcinogenesis in oropharyngeal squamous cell carcinoma (OPSCC). Whole-exome (WES) and whole-genome (WGS) sequencing were performed on peripheral blood and adjacent non-tumor and tumor specimens obtained from eight Korean HNSCC patients from 2013 to 2015. Next-generation sequencing yielded an average coverage of 94.3× for WES and 35.3× for WGS. In comparative genomic analysis of non-tumor and tumor tissue pairs, we were unable to identify common cancer-associated early mutations and copy number alterations (CNA) except in one pair. Interestingly, in this case, we observed that non-tumor tonsillar crypts adjacent to HPV-positive OPSCC appeared normal under a microscope; however, this tissue also showed weak p16 expression. WGS revealed the infection and integration of high-risk type HPV16 in this tissue as well as in the matched tumor. Furthermore, WES identified shared and tumor-specific genomic alterations for this pair. Clonal analysis enabled us to infer the process by which this transitional crypt epithelium (TrCE) evolved into a tumor; this evolution was accompanied by the subsequent accumulation of genomic alterations, including an ERBB3 mutation and large-scale CNAs, such as 3q27-qter amplification and 9p deletion. We suggest that HPV16-driven OPSCC carcinogenesis is a stepwise evolutionary process that is consistent with a multistep carcinogenesis model. Our results highlight the carcinogenic changes driven by HPV16 infection and provide a basis for the secondary prevention of OPSCC.

참고문헌 (32)

  1. Fitzmaurice C, "Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: A systematic analysis for the global burden of disease study", JAMA Oncol, 3, pp.524~548 (2016)
  2. Gooi Z, "The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer", Laryngoscope, 126, pp.894~900 (2016)
  3. Chaturvedi K, "Human papillomavirus and rising oropharyngeal cancer incidence in the United States", J Clin Oncol, 29, pp.4294~4301 (2011)
  4. Chaturvedi K, "Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers", J Clin Oncol, 31, pp.4550~4559 (2013)
  5. Cancer Genome Atlas Network, "Comprehensive genomic characterization of head and neck squamous cell carcinomas", Nature, 517, pp.576~582 (2015)
  6. Wentzensen N, "Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract", Cancer Res, 64, pp.3878~3884 (2004)
  7. Vogelstein B, "The multistep nature of cancer", Trends Genet, 9, pp.138~141 (1993)
  8. Rietbergen M, "No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors", J Oral Pathol Med, 43, pp.137~142 (2014)
  9. Ilmarinen T, "Prevalence of high-risk human papillomavirus infection and cancer gene mutations in nonmalignant tonsils", Oral Oncol, 73, pp.77~82 (2017)
  10. Palmer E, "Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: implications for tonsil cancer precursor lesions", Int J Cancer, 135, pp.2437~2443 (2014)
  11. Gillison L, "Prevalence of oral HPV infection in the United States, 2009-2010", JAMA, 307, pp.693~703 (2012)
  12. Alexandrov B, "Signatures of mutational processes in human cancer", Nature, 500, pp.415~421 (2013)
  13. Tabor P, "Genetically altered fields as origin of locally recurrent head and neck cancer:a retrospective study", Clin Cancer Res, 10, pp.3607~3613 (2004)
  14. Brennan A, "Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck", N Engl J Med, 332, pp.429~435 (1995)
  15. Wood M, "The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing", J Pathol, 237, pp.296~306 (2015)
  16. Ezaldein H, "Grading of aypia in genital skin lesions: routine microscopic evaluation and use of p16 immunostaining", J Cutan Pathol, 42, pp.519~526 (2015)
  17. Gultekin E, "P16(INK 4a) and Ki-67 expression in human papilloma virus-related head and neck mucosal lesions", Invest Clin, 56, pp.47~59 (2015)
  18. Tabrizi N, "Evaluation of p16INK4a immunostaining for the detection of high-grade changes in cervical cytology", Pathology, 47, pp.314~319 (2015)
  19. Trimble L, "Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2", 3: a randomised, double-blind, placebocontrolled phase 2b trial, 2015, pp.386, 2078~2088
  20. Marescalco S, "Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma", J Oral Pathol Med, 43, pp.20~27 (2014)
  21. Singh B, "Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas", Am J Pathol, 161, pp.365~371 (2002)
  22. Cancer Genome Atlas Research, "Integrated genomic and molecular characterization of cervical cancer", Nature, 545, pp.378~384 (2017)
  23. Holsinger C, "Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results", Arch Otolaryngol Head Neck Surg, 131, pp.583~591 (2005)
  24. Rhie A, "Genomic copy Number Variations Characterize the Prognosis of Both P16-positive and P16-negative oropharyngeal squamous cell carcinoma after curative resection", Medicine (Baltimore), 94, pp.e2187~ (2015)
  25. Hirsch R, "Epidermal growth factor receptor in non-small-cell lung carcinomas:correlation between gene copy number and protein expression and impact on prognosis", J Clin Oncol, 21, pp.3798~3807 (2003)
  26. Park WS, "Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators", Head Neck, 34, pp.1408~1417 (2012)
  27. Li H, "Fast and accurate short read alignment with Burrows-Wheeler transform", Bioinformatics, 25, pp.1754~1760 (2009)
  28. McKenna A, "The genome analysis toolkit: a mapReduce framework for analyzing next-generation DNA sequencing data", Genome Res, 20, pp.1297~1303 (2010)
  29. Cibulski K, "Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples", Nat Biotechnol, 31, pp.213~219 (2013)
  30. Krumm N, "Copy number variation detection and genotyping from exome sequence data", Genome Res, 22, pp.1525~1532 (2012)
  31. Rosenthal R, "DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution", Genome Biol, 17, pp.31~ (2016)
  32. Larson B, "PurBayes: estimating tumor cellularity and subclonality in next-generation sequencing data", Bioinformatics, 29, pp.1888~1889 (2013)

관련 논문AI추천

Prevalence of high-risk human papillomavirus and its genotype distribution in head and neck squamous cell carcinomas김민식, 김유일, 이연수, 주영훈대한병리학회 · Journal of Pathology and Translational Medicine2020 · 제54권 제5호Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma윤탁, 장현, 강은주, 고윤호, 권정혜, 김민경, 김범석, 김상우, 김주항, 김지원, 김지은, 김진수, 김혜련, 남병호, 박건욱, 안명주, 안희경, 윤환중, 이근욱, 이현우, 임선민, 전상훈, 정동민, 조병철, 조상희, 최재우, 최종권, 홍지형, 황인규대한암학회 · Cancer Research and Treatment2019 · 제51권 제1호HPV Genotyping in Squamous Cell Carcinoma of Upper Aerodigestive Tract김영, 김성순, 남종희, 민병우, 박창수, 정운재, 정은희, 최유덕대한병리학회 · Journal of Pathology and Translational Medicine2010 · 제44권 제5호The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation고영혜, 김태욱, 백정환, 손영익, 최성용대한이비인후과학회 · Clinical and Experimental Otorhinolaryngology2012 · 제5권 제4호Poor prognostic factors in human papillomavirus- positive head and neck cancer: who might not be candidates for de-escalation treatment?권성근, 권택균, 김동완, 김범석, 김진호, 김태민, 박성준, 성명훈, 옥찬영, 우홍균, 유신혜, 전윤경, 정경천, 정은재, 허대석, J. Hun Hah대한내과학회 · The Korean Journal of Internal Medicine2019 · 제34권 제6호Human Papillomavirus Prevalence and Cell Cycle Related Protein Expression in Tonsillar Squamous Cell Carcinomas of Korean Patients with Clinicopathologic Analysis김상윤, 김성배, 남순열, 노종렬, 이미지, 이상욱, 조경자, 최승호대한병리학회 · Journal of Pathology and Translational Medicine2013 · 제47권 제2호

이 간행물의 다른 논문 (10건)